Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Peyronie's Disease
NCT00812838Phase 2Completed
- Start
- Aug 2009
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Peyronie's disease. Started Aug 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT00812838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812838.